Calliditas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Calliditas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Calliditas Today - Breaking & Trending Today

Calliditas Therapeutics: In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action

STOCKHOLM, May 16, 2024 /PRNewswire/ Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that it will hold an in-person and virtual R&D day ....

United States , United Kingdom , Jonathan Barratt , Garethj Thomas , Gareth Thomas , Phd University Hospital Southampton , Renal Research Group , Life Sciences , University Of Leicester , American Society Of Nephrology Kidney Health Initiative , Iga Nephropathy Network , University Of Southampton , Rare Disease Group , Inderes Event Studio , University Hospital Southampton , Experimental Pathology , United Kingdom National Registry , Rare Kidney Diseases , In Ternational Iga Nephropathy , Chief Investigator , American Society , Nephrology Kidney Health Initiative , Identifying Surrogate Endpoints , Clinical Trials , Iga Nephropathy Work , Ihr Portfolio ,

Calliditas Therapeutics : Termination of Open Market Sale Agreement - Form 6-K

Termination of Open Market Sale Agreement

On June 7, 2023, Calliditas Therapeutics AB notified Jefferies LLC of its decision to terminate the Open Market Sale AgreementSM,. | June 8, 2023 ....

United States , Company Registration Statement On Form , Company American Depositary , Open Market Sale , Calliditas Therapeutics , Sales Agreement , American Depositary Shares , Common Shares , Securities Act , Nasdaq Global Select Market , Termination Date , Registration Statement , Registration Statements , Calliditas Therapeutics Ab Publ Stock Exchange , Press Release , Ale Caltx Se0010441584 ,

Calliditas Therapeutics: Calliditas Announces Late-Breaking Presentations at the 60th European Renal Association (ERA) Congress 2023

STOCKHOLM, May 5, 2023 /PRNewswire/ Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") announced upcoming data presentations from the NeflgArd Phase 3 Study ....

United Kingdom , United States , Richard Philipson , Richard Lafayette , Karen Molyneux , University Of Leicester , Exchange Commission , European Renal Association , European Commission , Nasdaq Stockholm , Neflgard Phase , Nefigard Phase , Presentation Details , Stanford Healthcare , Kidney Inflammation , Iga Nephropathy , Poster Details , Full Prescribing , Primary Immunoglobulin , American Depositary Shares , Nasdaq Global Select Market , Private Securities Litigation Reform Act , Investor Relations , Calliditas Therapeutics , Why Target , Treat Iga ,

Notice of annual general meeting of Calliditas Therapeutics AB (publ)

STOCKHOLM, April 28, 2023 /PRNewswire/ The shareholders of Calliditas Therapeutics AB (publ) ("Calliditas Therapeutics"), Reg. No. 556659-9766, with registered office in Stockholm, are summoned ....

United States , Jakob Grunditz , Alfred Driscoll , Fredrik Johansson , Monte Carlo , Molly Henderson , Elmar Schnee , Henrik Stenqvist , Stiftelsen Industrifonden , Patrik Sobocki Stiftelsen Industrifonden , Hilde Furberg , European Commission , Remuneration Committee , European Union Member States , Oxigene Inc , Swedish Companies Registration Office , Bentley University , Swedish Bar Association , Swedish Companies , Calliditas Therapeutics , Euroclear Sweden , Karl Tobieson , Patrik Sobocki , Diane Parks , Flexion Theraputics , Calliditas Therapeutic ,

Calliditas Therapeutics: Calliditas to participate in upcoming investor conferences

STOCKHOLM, March 31, 2023 /PRNewswire/ Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced its management's participation in the following investor ....

United States , Stefan Klotter , Renee Aguiar Lucander , Marie Galay , Conferences Press Release Eng , European Commission , Kempen Life Sciences Conference , European Union Member States , Nasdaq Stockholm , Guggenheim Genomic Medicines , Rare Disease Days Conference , Lotte New York , Iga Nephropathy , Iga Nephropathy Treatment , Embracing Change , Better Patient , American Depositary Shares , Nasdaq Global Select Market , Diese Aktien , Profi Stefan Klotter ,